Inflammatory and angiogenic biomarkers in diabetic retinopathy
Biochemia medica · 15.10.2020 · 30 (3) · 385-399
DOI: 10.11613/bm.2020.030502 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemia medica, online erschienen am 12.10.2020. Verfasst von Snježana Kaštelan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Clinical Hospital Dubrava, Zagreb, Croatia. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes mellitus (DM) and a leading cause of blindness in working-age adults in developed countries. Numerous investigations have recognised inflammation and angiogenesis as important factors in the development of this complication of diabetes. Current methods of DR treatment are predominantly used at advanced stages of the disease and could be associated with serious side effects. Therefore, new diagnostic methods are needed in order to identify the initial stages of DR as well as monitoring the effects of applied therapy. Biochemical biomarkers are molecules found in blood or other biological fluid and tissue that indicate the existence of an abnormal condition or disease. They could be a valuable tool in detecting early stages of DR, identifying patients most susceptible to retinopathy progression and monitoring treatment outcomes. Biomarkers related to DR can be measured in the blood, retina, vitreous, aqueous humour and recently in tears. As the retina represents a small part of total body mass, a circulating biomarker for DR needs to be highly specific. Local biomarkers are more reliable as indicators of the retinal pathology; however, obtaining a sample of aqueous humour, vitreous or retina is an invasive procedure with potential serious complications. As a non-invasive novel method, tear analysis offers a promising direction in further research for DR biomarker detection. The aim of this paper is to review systemic and local inflammatory and angiogenic biomarkers relevant to this sight threatening diabetic complication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Clinical Hospital Dubrava, Zagreb, Croatia.
- School of Medicine, University of Zagreb, Zagreb, Croatia.
- Augenzentrum Mühldorf, Überörtliche Gemeinschaftspraxis, Mühldorf am Inn, Germany.
- Department of Ophthalmology, General Hospital Dubrovnik, Dubrovnik, Croatia.
Zitieren
APA
Kaštelan, S., Orešković, I., Bišćan, F., Kaštelan, H., & Gverović Antunica, A. (2020). Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochemia medica, 30(3), 385-399. https://doi.org/10.11613/bm.2020.030502
Vancouver
Kaštelan S, Orešković I, Bišćan F, Kaštelan H, Gverović Antunica A. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochemia medica. 2020;30(3):385-399. doi:10.11613/bm.2020.030502
BibTeX
@article{Katelan2020,
author = {Kaštelan, Snježana and Orešković, Ivana and Bišćan, Filip and Kaštelan, Helena and Gverović Antunica, Antonela},
title = {Inflammatory and angiogenic biomarkers in diabetic retinopathy},
journal = {Biochemia medica},
year = {2020},
volume = {30},
number = {3},
pages = {385--399},
doi = {10.11613/bm.2020.030502}
}
EUVIMED